Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/154411
Full metadata record
DC FieldValueLanguage
dc.creatorCarrilho, C
dc.creatorFontes, F
dc.creatorTulsidás, S
dc.creatorLorenzoni, C
dc.creatorFerro, J
dc.creatorBrandão, M
dc.creatorFerro, A
dc.creatorLunet, N
dc.date.accessioned2023-11-14T12:04:01Z-
dc.date.available2023-11-14T12:04:01Z-
dc.date.issued2019
dc.identifier.issn0959-8278
dc.identifier.issn1473-5709
dc.identifier.urihttps://hdl.handle.net/10216/154411-
dc.description.abstractThere is scarce information on cancer incidence in Mozambique. We aimed to describe cancer incidence data from the Cancer Registry of the Maputo Central Hospital (MCH) in 2015–2016, for Maputo City dwellers, and to compare the incidence rates with those observed in 1956–1961. Cancers with incidence data in 2015–2016 were identified by the Cancer Registry of the MCH. Crude and age-standardized incident rates (ASIR, per 100 000) – direct method, world standard population – were computed for Maputo City, under the assumption that most cancer cases among this population were identified at the MCH. A total of 1707 incident cases in Maputo City dwellers were registered (76.6% confirmed histologically). Prostate cancer, Kaposi sarcoma, and liver cancer were the most frequent in men (ASIR: 24.5, 19.8, and 13.3, respectively). Cervical and breast cancers, and Kaposi sarcoma were the most common among women (ASIR: 32.4, 11.8, and 9.5, respectively). Compared with the data from 1956 to 1961, the most pronounced declines in ASIR were for bladder and liver cancers, in both sexes, and increases were greater for prostate cancer among men (172.2%) and breast cancer (237.1%) among women. Our study highlights the high frequency of infection-related cancers in Maputo, but also of those related to the ongoing demographic and socioeconomic transition.
dc.description.sponsorshipThis study was funded by ‘Fundação Calouste Gulbenkian’ and partner institutions: ‘Camões – Instituto da Cooperação e da Língua’, ‘Fundação Millennium-BCP’ and ‘Banco Moçambicano BIM’, under the Project ‘Atenção Integrada ao Doente Oncologico’. In addition, this study was funded by FEDER through the Operational Programme Competitiveness and Internationalization and national funding from the Foundation for Science and Technology – FCT (Portuguese Ministry of Science, Technology and Higher Education) under the ‘Unidade de Investigação em Epidemiologia – Instituto de Saúde Pública da Universidade do Porto (EPIUnit)’ (POCI-01-0145-FEDER-006862; Ref. UID/DTP/04750/2013). Individual PhD grants attributed to AF (PD/BD/105823/2014) and FF (SFRH/BD/92630/2013) were supported by FCT and the ‘Programa Operacional Capital Humano’ (POCH/FSE).
dc.language.isoeng
dc.publisherLippincott, Williams & Wilkins
dc.relation.ispartofEur J Cancer Prev. 2019 Jul;28(4):373-376. doi: 10.1097/CEJ.0000000000000457.
dc.rightsrestrictedAccess
dc.titleCancer incidence in Mozambique in 2015-2016: data from the Maputo Central Hospital Cancer Registry
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto
dc.identifier.doi10.1097/CEJ.0000000000000457
dc.relation.publisherversionhttps://journals.lww.com/eurjcancerprev/abstract/2019/07000/cancer_incidence_in_mozambique_in_2015_2016__data.18.aspx
Appears in Collections:ISPUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
carrilho-ejcp-2019.pdf
  Restricted Access
119.59 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.